-
41
Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
Published 2015-01-01“…A few case reports have described an association between IFN therapy and the development of irreversible pulmonary arterial hypertension (PAH), and it is currently listed as a possible drug-induced cause of PAH in the most recent classification of pulmonary hypertension. …”
Get full text
Article -
42
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities
Published 2025-01-01Subjects: “…Elderly pulmonary arterial hypertension…”
Get full text
Article -
43
-
44
Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis
Published 2022-01-01“…Pulmonary arterial hypertension (PAH) is a progressive and complex pulmonary vascular disease with poor prognosis. …”
Get full text
Article -
45
Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
Published 2025-05-01Subjects: “…Pulmonary Arterial Hypertension…”
Get full text
Article -
46
The 50‐year‐old pulmonary artery catheter: the tale of a foretold death?
Published 2020-06-01Get full text
Article -
47
Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
Published 2025-01-01Subjects: Get full text
Article -
48
Pulmonary Hypertension due to a Pulmonary Artery Leiomyosarcoma: A Case Report
Published 2013-01-01“…Background. Primary pulmonary artery sarcomas are very rare and their histologic type, called leiomyosarcoma, is even rarer. …”
Get full text
Article -
49
Investigation of the Pulmonary Artery Hypertension Using an Ad Hoc OpenFOAM CFD Solver
Published 2024-12-01Subjects: Get full text
Article -
50
Rare Case of a Calcified Catheter-Related Sheath Embolizing to the Right Pulmonary Artery
Published 2020-01-01“…We report the case of catheter-related sheath embolization to the right pulmonary artery in a child, as confirmed on CT.…”
Get full text
Article -
51
Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension
Published 2025-01-01“…Furthermore, the concentrations of aloperine in the lungs of the NLCs group were 1.79, 3.78, and 2.30 times higher than those in the solution group at three time points (0.25 h, 1.5 h, 4 h), suggesting that NLCs can increase the accumulation of aloperine in the lungs.Conclusion: Our findings suggest that NLCs loaded with aloperine could offer a promising strategy for the treatment of pulmonary arterial hypertension.Keywords: aloperine, nanostructured lipid carrier, aerosol inhalation, pharmacokinetics…”
Get full text
Article -
52
Extranodal Rosai–Dorfman Disease Presenting as a Mediastinal Mass with Pulmonary Artery Invasion
Published 2018-01-01“…While case reports of extranodal involvement in nearly every organ system exist, documented instances of mediastinal and pulmonary artery involvement are particularly rare. This study describes the case of a middle-aged woman presenting with new onset right heart failure who was found to have extranodal RDD in the form of a large mediastinal mass with invasion and occlusion of the main pulmonary arteries.…”
Get full text
Article -
53
Necrotizing pneumonia causing left descending pulmonary artery pseudoaneurysm: A rare entity
Published 2025-01-01Get full text
Article -
54
Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension
Published 2005-01-01“…The Canadian Cardiovascular Society and the Canadian Thoracic Society requested a position statement on pulmonary arterial hypertension from leading Canadian experts. …”
Get full text
Article -
55
Information Experiences and Needs in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Published 2014-01-01“…Background. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal, noncurable, but treatable diseases that strongly affect the patients. …”
Get full text
Article -
56
CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
Published 2021-01-01“…The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. …”
Get full text
Article -
57
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions
Published 2024-12-01Subjects: Get full text
Article -
58
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Published 2025-02-01Subjects: “…Pulmonary arterial hypertension…”
Get full text
Article -
59
The Association of the Pulmonary Artery Pulsatility Index and Right Ventricular Function after Cardiac Surgery
Published 2024-01-01“…Background. The pulmonary artery pulsatility index (PAPi) has been shown to correlate with right ventricular (RV) failure in patients with cardiac disease. …”
Get full text
Article -
60
In Situ Thrombosis of Small Pulmonary Arteries in Pulmonary Hypertension Developing after Chemotherapy for Malignancy
Published 2015-01-01“…Autopsy showed complete occlusion of the peripheral small pulmonary arteries and veins by thrombi. These results demonstrate that in situ thrombosis in the small pulmonary arteries could cause pulmonary hypertension after chemotherapy.…”
Get full text
Article